SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Share Price Hong Kong S.E.
Equities
2196
CNE100001M79
Pharmaceuticals
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.24 HKD | -1.13% |
|
+4.08% | -28.00% |
| Sales 2024 * | 45.05B 6.22B 48.67B 496B | Sales 2025 * | 50.8B 7.01B 54.89B 559B | Capitalization | 56.6B 7.81B 61.15B 623B |
|---|---|---|---|---|---|
| Net income 2024 * | 3.56B 492M 3.85B 39.24B | Net income 2025 * | 4.28B 591M 4.62B 47.1B | EV / Sales 2024 * | 1.6 x |
| Net Debt 2024 * | 15.69B 2.17B 16.95B 173B | Net Debt 2025 * | 17.77B 2.45B 19.19B 196B | EV / Sales 2025 * | 1.46 x |
| P/E ratio 2024 * |
17.6
x | P/E ratio 2025 * |
14.6
x | Employees | 40,370 |
| Yield 2024 * |
1.76% | Yield 2025 * |
2.07% | Free-Float | 63.42% |
More Fundamentals
* Assessed data
More news
More press releases
More news
| 1 day | -1.13% | ||
| 1 week | +4.08% | ||
| Current month | -4.38% | ||
| 1 month | -5.41% | ||
| 3 months | -11.94% | ||
| 6 months | -34.26% | ||
| Current year | -28.00% |
1 week
11.66
12.60
1 month
11.3213.08
Current year
11.3217.18
1 year
11.3223.20
3 years
11.3282.00
5 years
11.3282.00
10 years
11.3282.00
| Managers | Title | Age | Since |
|---|---|---|---|
De Yong Wen
CEO | Chief Executive Officer | 52 | - |
Dong Ming Li
PSD | President | 55 | 28/10/20 |
Yi Fang Wu
CHM | Chairman | 54 | 31/03/04 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Fang Yao
BRD | Director/Board Member | 54 | 08/04/10 |
Qi Yu Chen
BRD | Director/Board Member | 52 | 31/03/94 |
Xiao Hui Guan
BRD | Director/Board Member | 53 | - |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.37% | 4 M€ | -27.92% | ||
| 0.63% | 2 M€ | -14.86% | - | |
| 0.21% | 3 M€ | +0.62% | - | |
| 0.18% | 2 M€ | -14.14% | ||
| 0.16% | 4 M€ | -11.56% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/04/24 | 12.24 | -1.13% | 2 230 505 |
| 29/04/24 | 12.38 | +0.98% | 4,958,200 |
| 26/04/24 | 12.26 | +2.17% | 3,793,008 |
| 25/04/24 | 12 | +1.18% | 3,075,877 |
| 24/04/24 | 11.86 | +0.85% | 2,873,012 |
Delayed Quote Hong Kong S.E., April 30, 2024 at 06:01 am
More quotes
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a pharmaceutical group organized around 4 areas of activities:
- research, development and manufacturing of medicines (72.1% of net sales): for the treatment of cardiovascular diseases, digestive tract, metabolism, central nervous system and blood system disorders, and infectious diseases;
- sale of medical equipments and diagnosis products (17.3%);
- medical and hospital services (10.5%);
- other (0.1%).
China accounts for 72.9% of net sales.
Sector
Pharmaceuticals
Calendar
25/08/2024
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
23.71
CNY
Average target price
29.75
CNY
Spread / Average Target
+25.47%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +26.47% | 664B | |
| +26.74% | 567B | |
| -6.33% | 354B | |
| +19.35% | 330B | |
| +4.23% | 286B | |
| +13.43% | 234B | |
| +4.71% | 199B | |
| -9.53% | 196B | |
| -4.04% | 148B |
- Stock Market
- Equities
- 600196 Stock
- 2196 Stock
